Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome

被引：19
|
作者：
Brink, Mariska [1 ]
Everaars, Niek [1 ]
de Pont, Anne-Cornelie J. M. [1 ]
机构：
[1] Dijklander Ziekenhuis, Hoorn, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 381卷 / 08期
关键词：
PRONE POSITION; VENTILATION; CARE; ARDS;
D O I：
10.1056/NEJMc1908874
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To the Editor: The Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) trial (May 23 issue),(1) which involved patients with the acute respiratory distress syndrome (ARDS), showed no significant difference in mortality at 90 days between the cisatracurium group and the control group. This finding is contrary to the results of the ARDS et Curarisation Systematique (ACURASYS) trial published in 2010, in which the adjusted 90-day mortality was lower in the cisatracurium group than in the placebo group.(2) However, the crude 90-day mortality in the ACURASYS trial did not differ significantly between the intervention group and the control group (31.6% vs. . . .
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [41] Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation
    Kressin, Christian
    Thompson Bastin, Melissa
    Ather, Ayesha
    Gopinath, Anil
    Srour, Habib
    Schadler, Aric
    Pandya, Komal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (11): : 1415 - 1420
  • [42] Sedation Practices During Continuous Neuromuscular Blockade for the Acute Respiratory Distress Syndrome Are Associated With Prolonged Mechanical Ventilation
    Dunbar, P. J.
    Sottile, P. D.
    Ho, M.
    Kiser, T.
    Vandivier, R.
    Burnham, E. L.
    Moss, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis
    Hua, Yusi
    Ou, Xiaofeng
    Li, Qian
    Zhu, Tao
    PLOS ONE, 2020, 15 (01):
  • [44] NEUROMUSCULAR BLOCKING AGENTS FOR ACUTE RESPIRATORY DISTRESS SYNDROME: A SYSTEMATIC REVIEW
    Kuriyama, Akira
    Kamei, Jun
    CRITICAL CARE MEDICINE, 2019, 47
  • [45] COMPARING TITRATION OF CONTINUOUS NEUROMUSCULAR BLOCKERS IN ACUTE RESPIRATORY DISTRESS SYNDROME
    Maier, Arilyn
    Collier, Tia
    Kolar, Rachel
    Shible, Ahmed
    Roberts, Olivia
    Westlake, Evan
    Merritt, Tyler
    Hauser, Paloma
    Hung, Jerry
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [46] Is Cisatracurium the Neuromuscular Blocking Agent of Choice in Acute Respiratory Distress Syndrome?
    Huang, David T.
    Papazian, Laurent
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (07) : 849 - 850
  • [47] Critical illness neuromuscular abnormalities in patients with acute respiratory distress syndrome
    Mendez-Tellez, PA
    Smith, K
    CRITICAL CARE MEDICINE, 2005, 33 (11) : 2723 - 2724
  • [48] TIMING OF ADMINISTRATION OF NEUROMUSCULAR BLOCKING AGENTS IN ACUTE RESPIRATORY DISTRESS SYNDROME
    Makowski, Courtney
    Lizza, Bryan
    CRITICAL CARE MEDICINE, 2019, 47
  • [49] Respiratory distress syndrome and acute respiratory distress syndrome: Can early diagnosis facilitate a better outcome?
    Marraro, Giuseppe A.
    PEDIATRIC CRITICAL CARE MEDICINE, 2012, 13 (02) : 219 - 222
  • [50] Early fibroproliferation in the acute respiratory distress syndrome.
    Marshall, RP
    Bellingan, G
    Puddicombe, A
    Goldsack, N
    Chambers, R
    McAnulty, R
    Laurent, G
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A378 - A378
12345